Schedule 13G ownership disclosure

SUTRO BIOPHARMA INC

Common Stock, $0.001 par value · CUSIP: 869367102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 0.00 · Class: 0%

  • AVERILL MASTER FUND, LTD.

    Shares: 0.00 · Class: 0%

  • AARON COWEN

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-000953
Form type
SCHEDULE 13G/A
Filer
SUTRO BIOPHARMA, INC.
CIK
CIK 1382101
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub